Pathway-targeted pharmacogenomics of CYP1A2 in human liver

Frontiers in Pharmacology

Volumn 1 NOV, Issue , 2010, Pages

  Klein, Kathrin ^a   Winter, Stefan ^a   Turpeinen, Miia ^a   Schwab, Matthias ^a,b   Zanger, Ulrich M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Candidate gene; Cyp1a2; Cytochrome P450; Multivariate analysis; Non genetic factors; Pharmacogenetics; Pharmacogenomics; Snp

Indexed keywords

EID: 80053509605     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2010.00129     Document Type: Article

References (62)

1. Abnet, C. C., Fagundes, R. B., Strickland, P. T., Kamangar, F., Roth, M. J., Taylor, P. R., and Dawsey, S. M. (2007). The influence of genetic polymorphisms in Ahr, CYP1A1, CYP1A2, CYP1B1, GST M1, GST T1 and UGT1A1 on urine 1-hydroxypyrene glucuronide concentrations in healthy subjects from Rio Grande do Sul, Brazil. Carcinogenesis 28, 112-117.
2. Aklillu, E., Carrillo, J. A., Makonnen, E., Hellman, K., Pitarque, M., Bertilsson, L., and Ingelman-Sundberg, M. (2003). Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1. Mol. Pharmacol. 64, 659-669.
3. Allorge, D., Chevalier, D., Lo-Guidice, J., Cauffiez, C., Suard, F., Baumann, P., Eap, C. B., and Broly, F. (2003). Identification of a novel splice-site mutation in the CYP1A2 gene. Br. J. Clin. Pharmacol. 56, 341-344.
4. Auro, K., Kristiansson, K., Zethelius, B., Berne, C., Lannfelt, L., Taskinen, M., Jauhiainen, M., Perola, M., Peltonen, L., and Syvänen, A. (2008). USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study. Diabetologia 51, 464-472.
5. Bagwell, A. M., Bento, J. L., Mychaleckyj, J. C., Freedman, B. I., Langefeld, C. D., and Bowden, D. W. (2005). Genetic analysis of HNF4A polymorphisms in Caucasian-American type 2 diabetes. Diabetes 54, 1185-1190.
6. Bethke, L., Webb, E., Sellick, G., Rudd, M., Penegar, S., Withey, L., Qureshi, M., and Houlston, R. (2007). Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk. BMC Cancer 7, 123.
7. Bhat, A., Koul, A., Rai, E., Sharma, S., Dhar, M. K., and Bamezai, R. N. K. (2007). PGC-1alpha Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate casecontrol study. Hum. Genet. 121, 609-614.
8. Bin, P., Leng, S., Cheng, J., Dai, Y., Huang, C., Pan, Z., Niu, Y., Duan, H., Li, H., Liu, Q., Chen, W., and Zheng, Y. (2008). Association of aryl hydrocarbon receptor gene polymorphisms and urinary 1-hydroxypyrene in polycyclic aromatic hydrocarbon-exposed workers. Cancer Epidemiol. Biomarkers Prev. 17, 1702-1708.
9. Black, M. H., Fingerlin, T. E., Allayee, H., Zhang, W., Xiang, A. H., Trigo, E., Hartiala, J., Lehtinen, A. B., Haffner, S. M., Bergman, R. N., McEachin, R. C., Kjos, S. L., Lawrence, J. M., Buchanan, T. A., and Watanabe, R. M. (2008). Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes 57, 1048-1056.
10. Cauchi, S., Nead, K. T., Choquet, H., Horber, F., Potoczna, N., Balkau, B., Marre, M., Charpentier, G., Froguel, P., and Meyre, D. (2008). The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med. Genet. 9, 45.
11. Cauchi, S., Stücker, I., Cénée, S., Kremers, P., Beaune, P., and Massaad-Massade, L. (2003). Structure and polymorphisms of human aryl hydrocarbon receptor repressor (AhRR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer. Pharmacogenetics 13, 339-347.
12. Cauchi, S., Stücker, I., Solas, C., Laurent-Puig, P., Cénée, S., Hémon, D., Jacquet, M., Kremers, P., Beaune, P., and Massaad-Massade, L. (2001). Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer. Carcinogenesis 22, 1819-1824.
13. Cerhan, J. R., Liu-Mares, W., Fredericksen, Z. S., Novak, A. J., Cunningham, J. M., Kay, N. E., Dogan, A., Liebow, M., Wang, A. H., Call, T. G., Habermann, T. M., Ansell, S. M., and Slager, S. L. (2008). Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. Cancer Epidemiol. Biomarkers Prev. 17, 3161-3169.
14. Chen, D., Tian, T., Wang, H., Liu, H., Hu, Z., Wang, Y., Liu, Y., Ma, H., Fan, W., Miao, R., Sun, W., Wang, Y., Qian, J., Jin, L., Wei, Q., Shen, H., Huang, W., and Lu, D. (2009). Association of human aryl hydrocarbon receptor gene polymorphisms with risk of lung cancer among cigarette smokers in a Chinese population. Pharmacogenet. Genomics 19, 25-34.
15. Collings, A., Höyssä, S., Fan, M., Kähönen, M., Hutri-Kähönen, N., Marniemi, J., Juonala, M., Viikari, J. S. A., Raitakari, O. T., and Lehtimäki, T. J. (2008). Allelic variants of upstream transcription factor 1 associate with carotid artery intima-media thickness: the Cardiovascular Risk in Young Finns study. Circ. J. 72, 1158-1164.
16. Das, S. K., Sharma, N. K., Chu, W. S., Wang, H., and Elbein, S. C. (2008). Aryl hydrocarbon receptor nuclear translocator (ARNT) gene as a positional and functional candidate for type 2 diabetes and prediabetic intermediate traits: mutation detection, case-control studies, and gene expression analysis. BMC Med. Genet. 9, 16.
17. Deeb, S. S., and Brunzell, J. D. (2009). The role of the PGC1alpha Gly482Ser polymorphism in weight gain due to intensive diabetes therapy. PPAR Res. 2009, 649286.
18. Giuffrida, F. M. A., Furuzawa, G. K., Kasamatsu, T. S., Oliveira, M. M., Reis, A. F., and Dib, S. A. (2009). HNF1A gene polymorphisms and cardiovascular risk factors in individuals with late-onset autosomal dominant diabetes: a cross-sectional study. Cardiovasc. Diabetol. 8, 28.
19. Gragnoli, C., Lindner, T., Cockburn, B. N., Kaisaki, P. J., Gragnoli, F., Marozzi, G., and Bell, G. I. (1997). Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4 alpha binding site in the promoter of the hepatocyte nuclear factor-1 alpha gene. Diabetes 46, 1648-1651.
20. Gunes, A., and Dahl, M. (2008). Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms. Pharmacogenomics 9, 625-637.
21. Guo, S., Magnuson, V. L., Schiller, J. J., Wang, X., Wu, Y., and Ghosh, S. (2006). Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies. Am. J. Epidemiol. 164, 711-724.
22. Han, X., Ouyang, D., Chen, X., Shu, Y., Jiang, C., Tan, Z., and Zhou, H. (2002). Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2. Br. J. Clin. Pharmacol. 54, 540-543.
23. Hayashi, S. I., Watanabe, J., Nakachi, K., and Kawajiri, K. (1991). PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res. 19, 4797.
24. Holmkvist, J., Almgren, P., Lyssenko, V., Lindgren, C. M., Eriksson, K., Isomaa, B., Tuomi, T., Nilsson, P., and Groop, L. (2008). Common variants in maturityonset diabetes of the young genes and future risk of type 2 diabetes. Diabetes 57, 1738-1744.
25. Holmkvist, J., Cervin, C., Lyssenko, V., Winckler, W., Anevski, D., Cilio, C., Almgren, P., Berglund, G., Nilsson, P., Tuomi, T., Lindgren, C. M., Altshuler, D., and Groop, L. (2006). Common variants in HNF-1 alpha and risk of type 2 diabetes. Diabetologia 49, 2882-2891.
26. Holzapfel, C., Baumert, J., Grallert, H., Müller, A. M., Thorand, B., Khuseyinova, N., Herder, C., Meisinger, C., Hauner, H., Wichmann, H. E., Koenig, W., Illig, T., and Klopp, N. (2008). Genetic variants in the USF1 gene are associated with lowdensity lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Eur. J. Endocrinol. 159, 407-416.
27. Hustert, E., Zibat, A., Presecan-Siedel, E., Eiselt, R., Mueller, R., Fuss, C., Brehm, I., Brinkmann, U., Eichelbaum, M., Wojnowski, L., and Burk, O. (2001). Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4. Drug Metab. Dispos. 29, 1454-1459.
28. Ikeda, S., Kurose, K., Jinno, H., Sai, K., Ozawa, S., Hasegawa, R., Komamura, K., Kotake, T., Morishita, H., Kamakura, S., Kitakaze, M., Tomoike, H., Tamura, T., Yamamoto, N., Kunitoh, H., Yamada, Y., Ohe, Y., Shimada, Y., Shirao, K., Kubota, K., Minami, H., Ohtsu, A., Yoshida, T., Saijo, N., Saito, Y., and Sawada, J. (2005). Functional analysis of four naturally occurring variants of human constitutive androstane receptor. Mol. Genet. Metab. 86, 314-319.
29. Juang, J. J., de Las Fuentes, L., Waggoner, A. D., Gu, C. C., and Dávila-Román, V. G. (2010). Association and interaction of PPAR-complex gene variants with latent traits of left ventricular diastolic function. BMC Med. Genet. 11, 65.
30. Karban, A. S., Okazaki, T., Panhuysen, C. I. M., Gallegos, T., Potter, J. J., Bailey-Wilson, J. E., Silverberg, M. S., Duerr, R. H., Cho, J. H., Gregersen, P. K., Wu, Y., Achkar, J., Dassopoulos, T., Mezey, E., Bayless, T. M., Nouvet, F. J., and Brant, S. R. (2004). Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum. Mol. Genet. 13, 35-45.
31. Kayano, S., Suzuki, Y., Kanno, K., Aoki, Y., Kure, S., Yamada, A., and Matsubara, Y. (2004). Significant association between nonsyndromic oral clefts and arylhydrocarbon receptor nuclear translocator (ARNT). Am. J. Med. Genet. A 130A, 40-44.
32. King, C. R., Xiao, M., Yu, J., Minton, M. R., Addleman, N. J., Van Booven, D. J., Kwok, P., McLeod, H. L., and Marsh, S. (2007). Identification of NR1I2 genetic variation using resequencing. Eur. J. Clin. Pharmacol. 63, 547-554.
33. Kölsch, H., Lütjohann, D., Jessen, F., Popp, J., Hentschel, F., Kelemen, P., Friedrichs, S., Maier, W., and Heun, R. (2009). RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolism. J. Cell. Mol. Med. 13, 589-598.
34. Lamba, J., Lamba, V., Strom, S., Venkataramanan, R., and Schuetz, E. (2008). Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression. Drug Metab. Dispos. 36, 169-181.
35. Lausen, J., Thomas, H., Lemm, I., Bulman, M., Borgschulze, M., Lingott, A., Hattersley, A. T., and Ryffel, G. U. (2000). Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree. Nucleic Acids Res. 28, 430-437.
36. Lim, Y., and Huang, J. (2007). Pregnane X receptor polymorphism affects CYP3A4 induction via a liganddependent interaction with steroid receptor coactivator-1. Pharmacogenet. Genomics 17, 369-382.
37. Liu, X., Wang, Z., Yu, J., Lei, G., and Wang, S. (2010). Three polymorphisms in interleukin-1beta gene and risk for breast cancer: a meta-analysis. Breast Cancer Res. Treat. doi: 10.1007/s10549-010-0910-3.
38. Liu-Mares, W., Sun, Z., Bamlet, W. R., Atkinson, E. J., Fridley, B. L., Slager, S. L., de Andrade, M., and Goode, E. L. (2007). Analysis of variation in NF-kappaB genes and expression levels of NF-kappaB-regulated molecules. BMC Proc. 1(Suppl. 1), S126.
39. Long, J., Egan, K. M., Dunning, L., Shu, X., Cai, Q., Cai, H., Dai, Q., Holtzman, J., Gao, Y., and Zheng, W. (2006). Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Pharmacogenet. Genomics 16, 237-243.
40. Love-Gregory, L. D., Wasson, J., Ma, J., Jin, C. H., Glaser, B., Suarez, B. K., and Permutt, M. A. (2004). A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an ashkenazi jewish population. Diabetes 53, 1134-1140.
41. Lu, P., Liu, J., Melikishvili, M., Fried, M. G., and Chi, Y. (2008). Crystallization of hepatocyte nuclear factor 4 alpha (HNF4 alpha) in complex with the HNF1 alpha promoter element. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 64, 313-317.
42. Meex, S. J. R., van Vliet-Ostaptchouk, J. V., van der Kallen, C. J. H., van Greevenbroek, M. M. J., Schalkwijk, C. G., Feskens, E. J. M., Blaak, E. E., Wijmenga, C., Hofker, M. H., Stehouwer, C. D. A., and de Bruin, T. W. A. (2008). Upstream transcription factor 1 (USF1) in risk of type 2 diabetes: association study in 2000 Dutch Caucasians. Mol. Genet. Metab. 94, 352-355.
43. Merisalu, A., Punab, M., Altmäe, S., Haller, K., Tiido, T., Peters, M., and Salumets, A. (2007). The contribution of genetic variations of aryl hydrocarbon receptor pathway genes to male factor infertility. Fertil. Steril. 88, 854-859.
44. Muller, Y. L., Infante, A. M., Hanson, R. L., Love-Gregory, L., Knowler, W., Bogardus, C., and Baier, L. J. (2005). Variants in hepatocyte nuclear factor 4alpha are modestly associated with type 2 diabetes in Pima Indians. Diabetes 54, 3035-3039.
45. Murayama, N., Soyama, A., Saito, Y., Nakajima, Y., Komamura, K., Ueno, K., Kamakura, S., Kitakaze, M., Kimura, H., Goto, Y., Saitoh, O., Katoh, M., Ohnuma, T., Kawai, M., Sugai, K., Ohtsuki, T., Suzuki, C., Minami, N., Ozawa, S., and Sawada, J. (2004). Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes. J. Pharmacol. Exp. Ther. 308, 300-306.
46. Nakajima, M., Yokoi, T., Mizutani, M., Kinoshita, M., Funayama, M., and Kamataki, T. (1999). Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J. Biochem. 125, 803-808.
47. Naukkarinen, J., Gentile, M., Soro-Paavonen, A., Saarela, J., Koistinen, H. A., Pajukanta, P., Taskinen, M., and Peltonen, L. (2005). USF1 and dyslipidemias: converging evidence for a functional intronic variant. Hum. Mol. Genet. 14, 2595-2605.
48. Oleson, L., von Moltke, L. L., Greenblatt, D. J., and Court, M. H. (2010). Identification of polymorphisms in the 3′-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism. Xenobiotica 40, 146-162.
49. Oliver, P., Lubomirov, R., and Carcas, A. (2010). Genetic polymorphisms of CYP1A2, CYP3A4, CYP3A5, pregnane/steroid X receptor and constitutive androstane receptor in 207 healthy Spanish volunteers. Clin. Chem. Lab. Med. 48, 635-639.
50. Pucci, L., Geppetti, A., Maggini, V., Lucchesi, D., Maria Rossi, A., and Longo, V. (2007). CYP1A2 F21L and F186L polymorphisms in an Italian population sample. Drug Metab. Pharmacokinet. 22, 220-222.
51. Purdue, M. P., Lan, Q., Kricker, A., Vajdic, C. M., Rothman, N., and Armstrong, B. K. (2007). Vitamin D receptor gene polymorphisms and risk of non-Hodgkin's lymphoma. Haematologica 92, 1145-1146.
52. Reiner, A. P., Barber, M. J., Guan, Y., Ridker, P. M., Lange, L. A., Chasman, D. I., Walston, J. D., Cooper, G. M., Jenny, N. S., Rieder, M. J., Durda, J. P., Smith, J. D., Novembre, J., Tracy, R. P., Rotter, J. I., Stephens, M., Nickerson, D. A., and Krauss, R. M. (2008). Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am. J. Hum. Genet. 82, 1193-1201.
53. Ridker, P. M., Pare, G., Parker, A., Zee, R. Y. L., Danik, J. S., Buring, J. E., Kwiatkowski, D., Cook, N. R., Miletich, J. P., and Chasman, D. I. (2008). Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am. J. Hum. Genet. 82, 1185-1192.
54. Ryffel, G. U. (2001). Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J. Mol. Endocrinol. 27, 11-29.
55. Sookoian, S., Gemma, C., and Pirola, C. J. (2010). Influence of hepatocyte nuclear factor 4alpha (HNF4alpha) gene variants on the risk of type 2 diabetes: a meta-analysis in 49,577 individuals. Mol. Genet. Metab. 99, 80-89.
56. Wang, S., Fu, C., Wang, H., Shi, Y., Xu, X., Chen, J., Song, X., Sun, K., Wang, J., Fan, X., Wang, H., Yang, X., Huan, T., and Hui, R. (2007). Polymorphisms of the peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene are associated with hypertrophic cardiomyopathy and not with hypertension hypertrophy. Clin. Chem. Lab. Med. 45, 962-967.
57. Watanabe, T., Imoto, I., Kosugi, Y., Fukuda, Y., Mimura, J., Fujii, Y., Isaka, K., Takayama, M., Sato, A., and Inazawa, J. (2001). Human arylhydrocarbon receptor repressor (AHRR) gene: genomic structure and analysis of polymorphism in endometriosis. J. Hum. Genet. 46, 342-346.
58. Weedon, M. N., Owen, K. R., Shields, B., Hitman, G., Walker, M., McCarthy, M. I., Hattersley, A. T., and Frayling, T. M. (2005). A large-scale association analysis of common variation of the HNF1alpha gene with type 2 diabetes in the U.K. Caucasian population. Diabetes 54, 2487-2491.
59. Wong, J. M., Okey, A. B., and Harper, P. A. (2001). Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction. Biochem. Biophys. Res. Commun. 288, 990-996.
60. Zhang, J., Kuehl, P., Green, E. D., Touchman, J. W., Watkins, P. B., Daly, A., Hall, S. D., Maurel, P., Relling, M., Brimer, C., Yasuda, K., Wrighton, S. A., Hancock, M., Kim, R. B., Strom, S., Thummel, K., Russell, C. G., Hudson, J. R., Schuetz, E. G., and Boguski, M. S. (2001). The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics 11, 555-572.
61. Zhang, Z. Y., Fasco, M. J., Huang, L., Guengerich, F. P., and Kaminsky, L. S. (1996). Characterization of purified human recombinant cytochrome P4501A1-Ile462 and -Val462: assessment of a role for the rare allele in carcinogenesis. Cancer Res. 56, 3926-3933.
62. Zhou, S., Chan, E., Zhou, Z., Xue, C. C., Lai, X., and Duan, W. (2009). Insights into the structure, function, and regulation of human cytochrome P450 1A2. Curr. Drug Metab. 10, 713-729.